Premia 5 Continuous is a medicine containing the active ingredient(s) conjugated estrogens + medroxyprogesterone. On this page you will find out more about Premia 5 Continuous, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: conjugated estrogens + medroxyprogesterone
Over 65 years of age?
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Information for medicine and pack size:
Premia 5 Continuous sugar coated tablet, 28
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Oestrogens with or without progestogens should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman. The PREMIA range is indicated: As replacement therapy for oestrogen deficiency states associated with the climacteric in women with an intact uterus most commonly manifested by: a) Moderate to severe vasomotor symptoms associated with oestrogen deficiency in natural and surgical menopause (sweating, hot flushes). Periodic re-evaluation with a view to short term treatment is recommended. b) Atrophic vaginitis. When prescribing solely for the treatment of symptoms of vaginal atrophy, topical vaginal products should be considered. There is no evidence that oestrogens are effective for anxiety or depression without associated vasomotor symptoms, and they should not be used to treat such conditions. For the prevention of postmenopausal osteoporosis. When prescribed solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at high risk of osteoporosis and future fracture and who are intolerant of, or contraindicated for non-oestrogen products approved for prevention of osteoporosis. Life style modifications and the risk benefit profile of PREMIA should be taken into careful consideration and discussed with the patient, to allow the patient to make an informed decision prior to prescribing( See PRECAUTIONS and DOSAGE AND ADMINISTRATION). See BOXED WARNING, particular when considering PREMIA for long- term usage.
Table of characteristics
Blue, oval, bi-convex, sugar coated tablet marked 0.625/5 in black ink.
Images are the copyright of the Pharmacy Guild of Australia
|Dosage Form||Tablet, sugar coated|
|Route of administration||Oral|
112 tablets: Prescription Only Medicine, or Prescription Animal Remedy
28 tablets: Prescription Only Medicine, or Prescription Animal Remedy
56 tablets: Prescription Only Medicine, or Prescription Animal Remedy
84 tablets: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||No information available|
|Life time||3 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 2 results
Premia 2.5 Continuous Tablets - myDr.com.au
Premia 2.5 Continuous Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Hormone replacement therapy - myDr.com.au
Hormone replacement therapy (HRT) is not a quick fix to the challenge of menopause, but it can be a useful tool in the overall management of menopause.
Read more on myDr website
Found 0 results